Search Results - "Kurzyna, M."

Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension by Galiè, Nazzareno, Ghofrani, Hossein A, Torbicki, Adam, Barst, Robyn J, Rubin, Lewis J, Badesch, David, Fleming, Thomas, Parpia, Tamiza, Burgess, Gary, Branzi, Angelo, Grimminger, Friedrich, Kurzyna, Marcin, Simonneau, Gérald

“…In this randomized trial involving patients with pulmonary hypertension, sildenafil (an inhibitor of phosphodiesterase type 5) was found to improve exercise…”
Get full text

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism by Pruszczyk, P, Kostrubiec, M, Bochowicz, A, Styczynski, G, Szulc, M, Kurzyna, M, Fijalkowska, A, Kuch-Wocial, A, Chlewicka, I, Torbicki, A

“…Plasma brain natriuretic peptide (BNP), released from myocytes of ventricles upon stretch, has been reported to differentiate pulmonary from cardiac dyspnoea…”
Get full text

Effects of the oral endothelin-receptor antagonist Bosentan on echocardiographic and Doppler measures in Patients with pulmonary arterial hypertension by GALIE, Nazzareno, HINDERLITER, Alan L, KURZYNA, Marcin, NAGUEH, Sherif F, BARST, Robyn, CHANNICK, Richard, DUJARDIN, Karl, KRONENBERG, Andrew, LECONTE, Isabelle, RAINISIO, Maurizio, RUBIN, Lewis, TORBICKI, Adam, FOURME, Thierry, SIMONNEAU, Gerald, PULIDO, Tomas, ESPINOLA-ZAVALETA, Nilda, ROCCHI, Guido, MANES, Alessandra, FRANTZ, Robert

“…The purpose of this study was to investigate the effects of bosentan (125 or 250 mg twice daily) on echocardiographic and Doppler variables in 85 patients with…”
Get full text

Proximal pulmonary emboli modify right ventricular ejection pattern by Torbicki, A, Kurzyna, M, Ciurzynski, M, Pruszczyk, P, Pacho, R, Kuch-Wocial, A, Szulc, M

“…Analysis of the systolic flow velocity curve (SFVC) in the right ventricular outflow tract is considered as an alternative to the tricuspid valve pressure…”
Get full text

Unlocking the Potential: PEGylation and Molecular Weight Reduction of Ionenes for Enhanced Antifungal Activity and Biocompatibility by Kurzyna, Jan M., Kopiasz, Rafał J., Paul, Martyna, Flont, Magdalena, Baranowska, Patrycja, Mierzejewska, Jolanta, Drężek, Karolina, Tomaszewski, Waldemar, Jastrzębska, Elżbieta, Jańczewski, Dominik

“…Numerous synthetic polymers, imitating natural antimicrobial peptides, have demonstrated potent antimicrobial activity, positioning them as potential…”
Get full text

Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome by Korniszewski, L, Kurzyna, M, Stolarski, B, Torbicki, A, Smerdel, A, Ploski, R

“…Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is caused by mutations in the autoimmune regulator (AIRE) gene, which has a central…”
Get full text

Short term clinical outcome of acute saddle pulmonary embolism by Pruszczyk, P, Pacho, R, Ciurzynski, M, Kurzyna, M, Burakowska, B, Tomkowski, W, Bochowicz, A, Torbicki, A

“…Wider application of spiral computed tomography (CT) not only improves diagnosis of acute pulmonary embolism (PE) (fig 1), but also allows for non-invasive…”
Get full text

Long‐term effects of acute pulmonary embolism on echocardiographic doppler indices and functional capacity by Ciurzyński, M., Kurzyna, M., Bochowicz, A., Lichodziejewska, B., Liszewska‐Pfejfer, D., Pruszczyk, P., Torbicki, A.

“…Background and hypothesis:Hemodynamic and functional consequences of acute pulmonary embolism (APE) are believed to be reversible with antithrombotic…”
Get full text

P886 Shoots from the whip: catheter tip migration and tromboembolic comlications of ventriculoatrial shunt for hydrocephalus in von Hippel Lindau disease - multimodality findings by Gosciniak, P, Larysz, B, Kurzyna, M

“…Abstract We report a rare nowadays case of 35 yo patient with von Hippel Lindau (VHL) disease and pulmonary hypertension as a severe complication of…”
Get full text

2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism by Konstantinides, Stavros V, Torbicki, Adam, Agnelli, Giancarlo, Danchin, Nicolas, Fitzmaurice, David, Galiè, Nazzareno, Gibbs, J Simon R, Huisman, Menno V, Humbert, Marc, Kucher, Nils, Lang, Irene, Lankeit, Mareike, Lekakis, John, Maack, Christoph, Mayer, Eckhard, Meneveau, Nicolas, Perrier, Arnaud, Pruszczyk, Piotr, Rasmussen, Lars H, Schindler, Thomas H, Svitil, Pavel, Vonk Noordegraaf, Anton, Zamorano, Jose Luis, Zompatori, Maurizio

Get full text

Mini nutritional assessment is a predictor of mortality and morbidity in patients with pulmonary arterial hypertension by Wieteska-Milek, M, Szmit, S, Florczyk, M, Betkier-Lipinska, K, Kusmierczyk-Droszcz, B, Zielinski, P, Krzesinski, P, Hoffman, P, Kurzyna, M

“…Abstract Background Malnutrition has been demonstrated as a predictor for unfavorable clinical outcomes in chronic heart failure, and may affect patients with…”
Get full text

Effects of beta blockers on outcome in patients with PAH with and without comorbid conditions: a Multicenter Prospective Cohort Study (BNP-PL) by Waligora, M, Kurzyna, M, Mularek-Kubzdela, T, Skoczylas, I, Chrzanowski, L, Blaszczak, P, Jaguszewski, M, Kusmierczyk, B, Ptaszynska-Kopczynska, K, Grzesk, G, Mizia-Stec, K, Doboszynska, A, Peregud-Pogorzelska, M, Lewicka, E, Kopec, G

“…Abstract Background The current guidelines do not recommend the use of beta-blockers (BB) in patients with pulmonary arterial hypertension (PAH) unless…”
Get full text

Types of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database by Mamzer, A, Waligora, M, Kurzyna, M, Mroczek, E, Mularek-Kubzdela, T, Pruszczyk, P, Gasior, M, Lewicka, E, Karasek, D, Kusmierczyk-Droszcz, B, Mizia-Stec, K, Ptaszynska, K, Jachec, W, Kopec, G, Kasprzak, J D

“…Abstract Introduction The COVID-19 pandemic significantly increased mortality in the group of patients (pts) with pulmonary hypertension (PH). However, there…”
Get full text

Specific therapies of pulmonary hypertension and prognosis in COVID-19: 18-months analysis of BNP-PL national database by Mamzer, A, Waligora, M, Kurzyna, M, Mroczek, E, Mularek-Kubzdela, T, Pruszczyk, P, Skoczylas, I, Lewicka, E, Karasek, D, Kusmierczyk-Droszcz, B, Mizia-Stec, K, Ptaszynska-Kopczynska, K, Jachec, W, Kopec, G, Kasprzak, J D

“…Abstract Introduction The SARS-CoV-2 pandemic had a significant impact on mortality in the group of patients (pts) with pulmonary hypertension (PH). Specific…”
Get full text

Impact of COVID-19 pandemics upon nationwide pulmonary hypertension cohort: 18-months analysis of BNP-PL national database by Mamzer, A, Kasprzak, J D, Waligora, M, Kurzyna, M, Mroczek, E, Mularek-Kubzdela, T, Pruszczyk, P, Lewicka, E, Karasek, D, Kusmierczyk-Droszcz, B, Mizia-Stec, K, Ptaszynska-Kopczynska, K, Skoczylas, I, Blaszczak, P, Kopec, G

“…Abstract Introduction Pulmonary hypertension (PH) patients may be vulnerable to SARS-CoV-2 infection, but large analytic studies on morbidity and mortality…”
Get full text

Atherosclerosis risk factors may be underestimated in patients with pulmonary hypertension associated with congenital heart disease – results of Polish snapshot registry by Mamzer, A, Kopec, G, Kusmierczyk-Droszcz, B, Skowron, W, Mroczek, E, Lewicka, E, Kaminski, K, Karasek, D, Mularek-Kubzdela, T, Mizia-Stec, K, Kurzyna, M, Gasior, Z, Ciurzynski, M, Plonska-Gosciniak, E, Kasprzak, J D

“…Abstract Introduction Classic risk factors of atherosclerosis may contribute to cardiovascular (CV) risk in patients (pts) with pulmonary hypertension…”
Get full text

Impact of COVID-19 pandemics upon pulmonary hypertension patients: insights from BNP-PL national database by Mamzer, A, Kasprzak, J D, Waligora, M, Kurzyna, M, Mroczek, E, Mularek-Kubzdela, T, Pruszczyk, P, Gasior, M, Lewicka, E, Karasek, D, Kusmierczyk-Droszcz, B, Mizia-Stec, K, Ptaszynska-Kopczynska, K, Jachec, W, Kopec, G

“…Abstract Introduction COVID-19 pandemic has caused not only an increase in overall and cardiovascular mortality, but also hindered access to health care,…”
Get full text

Management of purulent pericarditis by Tomkowski, W Z, Kuca, P, Gralec, R, Burakowski, J, Caban, P, Orlowski, T, Kurzyna, M

“…A 50 year old man was admitted to ICU due to purulent pericarditis, purulent inflammation of the soft tissue of the neck, purulent mediastinitis and pneumonia…”
Get more information

P5421Is soluble supression of tumorigenicity (sST2) a new biomarker in patients with right ventricular failure due to pulmonary hypertension? by Banaszkiewicz, M., Darocha, S., Pietrasik, A., Norwa, J., Dobosiewicz, A., Kepski, J., Florczyk, M., Manczak, R., Torbicki, A., Kurzyna, M.

Get full text

P2604A long-term outcome of patients with chronic thromboembolic pulmonary hypertension treated with different methods by Darocha, S., Pietura, R., Pietrasik, A., Dobosiewicz, A., Florczyk, M., Pilka, M., Norwa, J., Manczak, R., Wieteska, M., Banaszkiewicz, M., Szmit, S., Biederman, A., Torbicki, A., Kurzyna, M.

Get full text